Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates

Kishor Devalaraja-Narashimha; Cong Huang; Marc Cao; Ya Ping Chen; Anna Borodovsky; William C. Olson; Lori G. Morton; Marc W. Retter

doi:10.1371/journal.pone.0269749

Loading metrics

Open Access

Peer-reviewed

Research Article

Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates

Kishor Devalaraja-Narashimha,

Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America
⨯
Cong Huang,

Roles Formal analysis, Investigation, Methodology, Writing – review & editing

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America
⨯
Marc Cao,

Roles Formal analysis, Investigation, Methodology, Writing – review & editing

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America
⨯
Ya Ping Chen,

Roles Formal analysis, Writing – review & editing

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America
⨯
Anna Borodovsky,

Roles Conceptualization, Formal analysis, Writing – review & editing

Affiliation Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts, United States of America
⨯
William C. Olson,

Roles Formal analysis, Writing – review & editing

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America
⨯
Lori G. Morton,

Roles Formal analysis, Writing – review & editing

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America
⨯
Marc W. Retter

Roles Conceptualization, Formal analysis, Writing – review & editing

* E-mail: marc.retter@regeneron.com

Affiliation Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America

https://orcid.org/0000-0001-9414-5929

⨯

Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates

Kishor Devalaraja-Narashimha,
Cong Huang,
Marc Cao,
Ya Ping Chen,
Anna Borodovsky,
William C. Olson,
Lori G. Morton,
Marc W. Retter

Published: June 16, 2022
https://doi.org/10.1371/journal.pone.0269749

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Monkeys
Is the Subject Area "Monkeys" applicable to this article?

Thanks for your feedback.
Primates
Is the Subject Area "Primates" applicable to this article?

Thanks for your feedback.
Complement inhibitors
Is the Subject Area "Complement inhibitors" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Pharmacodynamics
Is the Subject Area "Pharmacodynamics" applicable to this article?

Thanks for your feedback.
Complement activation
Is the Subject Area "Complement activation" applicable to this article?

Thanks for your feedback.
Red blood cells
Is the Subject Area "Red blood cells" applicable to this article?

Thanks for your feedback.